Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Gerich

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
The American Journal of Gastroenterology|February 3, 2016
High Hope for Medical Marijuana in Digestive DisordersRobert W Isfort, Mark E Gerich
Nature Reviews. Gastroenterology & Hepatology|December 19, 2013
Towards personalized care in IBDMark E Gerich, Dermot P B McGovern
The American Journal of Gastroenterology|August 12, 2015
Response to Utomo et alRobert W Isfort, Colm B Collins, Mark E Gerich
Inflammatory Bowel Diseases|May 28, 2011
Multifocal pouch body adenocarcinoma following ileal pouch-anal anastomosis (IPAA) for ulcerative colitisMark E Gerich, Martine C McManus, Martin McCarter, et al.
The American Journal of Gastroenterology|September 10, 2014
Medical marijuana for digestive disorders: high time to prescribe?Mark E Gerich, Robert W Isfort, Bryan Brimhall, et al.
Gastro Hep Advances|August 12, 2024
Temporal Trends in Perceptions of Anti-tumor Necrosis Factor Risks and Benefits in an Online Community of Patients With Crohn's DiseaseAmneet K Hans, Mark E Gerich, Blair Fennimore, et al.
Inflammatory Bowel Diseases|January 13, 2017
Manipulation of the Endocannabinoid System in Colitis: A Comprehensive ReviewKristina L Leinwand, Mark E Gerich, Edward J Hoffenberg, et al.
Gastroenterology|January 2, 2008
Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibitionAndreas Robinson, Simon Keely, Jörn Karhausen, et al.
Journal of Crohn'S & Colitis|December 3, 2010
A prospective evaluation of the impact of allopurinol in pediatric and adult IBD patients with preferential metabolism of 6-mercaptopurine to 6-methylmercaptopurineMark E Gerich, J Antonio Quiros, James P Marcin, et al.
Inflammatory Bowel Diseases|March 23, 2013
Tacrolimus salvage in anti-tumor necrosis factor antibody treatment-refractory Crohn's diseaseMark E Gerich, Darrell S Pardi, David H Bruining, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
The American Journal of Gastroenterology|February 3, 2016
High Hope for Medical Marijuana in Digestive DisordersRobert W Isfort, Mark E Gerich
Nature Reviews. Gastroenterology & Hepatology|December 19, 2013
Towards personalized care in IBDMark E Gerich, Dermot P B McGovern
The American Journal of Gastroenterology|August 12, 2015
Response to Utomo et alRobert W Isfort, Colm B Collins, Mark E Gerich
Inflammatory Bowel Diseases|May 28, 2011
Multifocal pouch body adenocarcinoma following ileal pouch-anal anastomosis (IPAA) for ulcerative colitisMark E Gerich, Martine C McManus, Martin McCarter, et al.
The American Journal of Gastroenterology|September 10, 2014
Medical marijuana for digestive disorders: high time to prescribe?Mark E Gerich, Robert W Isfort, Bryan Brimhall, et al.
Gastro Hep Advances|August 12, 2024
Temporal Trends in Perceptions of Anti-tumor Necrosis Factor Risks and Benefits in an Online Community of Patients With Crohn's DiseaseAmneet K Hans, Mark E Gerich, Blair Fennimore, et al.
Inflammatory Bowel Diseases|January 13, 2017
Manipulation of the Endocannabinoid System in Colitis: A Comprehensive ReviewKristina L Leinwand, Mark E Gerich, Edward J Hoffenberg, et al.
Gastroenterology|January 2, 2008
Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibitionAndreas Robinson, Simon Keely, Jörn Karhausen, et al.
Journal of Crohn'S & Colitis|December 3, 2010
A prospective evaluation of the impact of allopurinol in pediatric and adult IBD patients with preferential metabolism of 6-mercaptopurine to 6-methylmercaptopurineMark E Gerich, J Antonio Quiros, James P Marcin, et al.
Inflammatory Bowel Diseases|March 23, 2013
Tacrolimus salvage in anti-tumor necrosis factor antibody treatment-refractory Crohn's diseaseMark E Gerich, Darrell S Pardi, David H Bruining, et al.
Pageof 4